Carbapenem-resistant bacteria in an intensive care unit: prevalence and associated factors

Authors

DOI:

https://doi.org/10.33448/rsd-v11i10.32629

Keywords:

Bacteria; Carbapenems; Intensive Care Units; Cross infection.

Abstract

Antimicrobial resistance is a global threat that requires different care and factors involved including a unified, multidimensional approach, with greater epidemiological surveillance. The objective this study was to review the prevalence and factors associated with healthcare-related infections (HAI) caused by bacteria resistant to carbapenems in adult patients admitted to the Intensive Care Unit (ICU). This was a cross-sectional study accomplished through the review of electronic medical records and microbiological tests of patients admitted to the ICU of a hospital in southern Santa Catarina between 2010 and 2017. Demographic, clinical and antimicrobial use data were part of the variables of interest. A total of 1,273 HAI cases were included, 11.5% of the hospital infection rate. The mean age of patients was 60.4±18.5 years; 58.7% of the patients were men. The main cause of hospitalization was cardiac-related diseases (35.8%) and the median hospital stay was 31 days. Of the total number of cases, 24% were due to carbapenem resistance. HAIs caused by Escherichia coli, coagulase-negative Staphylococcus/Staphylococcus aureus and Streptococcus sp. were the pathogens that showed greater resistance to carbapenems. Resistance to carbapenems was associated with longer hospital stay (p=0.014), surgical procedure (p<0.001), use of nasoenteral tube (p=0.048) and death (p=0.003). There was a high rate of infection by bacteria resistant to carbapenems. The observed rate of HAIs increased in frequency significantly over the duration of the study period.

References

Aliyu, S., Smaldone, A., & Larson, E. (2017). Prevalence of multidrug-resistant gram-negative bacteria among nursing home residents: A systematic review and meta-analysis. American journal of infection control, 45(5), 512–518. https://doi.org/10.1016/j.ajic.2017.01.022

Alp, E., & Damani, N. (2015). Healthcare-associated infections in intensive care units: epidemiology and infection control in low-to-middle income countries. Journal of infection in developing countries, 9(10), 1040–1045. https://doi.org/10.3855/jidc.6832

ANVISA. Agência Nacional de Vigilância Sanitária (2013) Critérios Diagnósticos de Infecção Relacionada à Assistência à Saúde. Disponível em: www.anvisa.gov.br

Axente, C., Licker, M., Moldovan, R., Hogea, E., Muntean, D., Horhat, F., Bedreag, O., Sandesc, D., Papurica, M., Dugaesescu, D., Voicu, M., & Baditoiu, L. (2017). Antimicrobial consumption, costs and resistance patterns: a two year prospective study in a Romanian intensive care unit. BMC infectious diseases, 17(1), 358. https://doi.org/10.1186/s12879-017-2440-7

Carvalho MR, Moreira ICCC, Amorim Neta FL, Guimarães MSO,Viana VGF, Oliveira FW. Incidência de bactérias multirresistentes em uma unidade de terapia intensiva. Rev Interdisciplinar. 2015;8(2):75–85.

Cieslinski, J. M., Arend, L., Tuon, F. F., Silva, E. P., Ekermann, R. G., Dalla-Costa, L. M., Higgins, P. G., Seifert, H., & Pilonetto, M. (2013). Molecular epidemiology characterization of OXA-23 carbapenemase-producing Acinetobacter baumannii isolated from 8 Brazilian hospitals using repetitive sequence-based PCR. Diagnostic microbiology and infectious disease, 77(4), 337–340. https://doi.org/10.1016/j.diagmicrobio.2013.07.018

Correa, L., Martino, M. D., Siqueira, I., Pasternak, J., Gales, A. C., Silva, C. V., Camargo, T. Z., Scherer, P. F., & Marra, A. R. (2013). A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection. BMC infectious diseases, 13, 80. https://doi.org/10.1186/1471-2334-13-80

Dehghan, F., Zolghadri, N., Boostani, V., Shafii, A., & Eftekhaari, T. E. (2016). Resistance of gram negative bacteria in hospital acquired pneumonia: a prospective study. The Brazilian journal of infectious diseases: an official publication of the Brazilian Society of Infectious Diseases, 20(1), 113–114. https://doi.org/10.1016/j.bjid.2015.11.006

Dereli, N., Ozayar, E., Degerli, S., Sahin, S., & Koç, F. (2013). Three-year evaluation of nosocomial infection rates of the ICU. Brazilian journal of anesthesiology (Elsevier), 63(1), 73–78. https://doi.org/10.1016/S0034-7094(13)70199-5

Garbati, M. A., Sakkijha, H., & Abushaheen, A. (2016). Infections due to Carbapenem Resistant Enterobacteriaceae among Saudi Arabian Hospitalized Patients: A Matched Case-Control Study. BioMed research international, 2016, 3961684. https://doi.org/10.1155/2016/3961684

Gavronski, S. (2017) Investigação da resistência aos carbapenêmicos em enterobactérias isoladas em um hospital de blumenau/sc: detecção laboratorial e aspectos epidemiológicos. Brasil: Programa de Pós Graduação em Farmácia, Universidade Federal de Santa Catarina.

Gomes, D. B., Genteluci, G. L., de Souza, M. J., Zahner, V., Carvalho, K. R., & Villas Bôas, M. H. (2016). Presence of the blaOXA-72 gene in Acinetobacter baumannii from a public hospital in Brazil. Journal of global antimicrobial resistance, 5, 90–91. https://doi.org/10.1016/j.jgar.2015.11.007

Guimarães, A. C., Donalisio, M. R., Santiago, T. H., & Freire, J. B. (2011). Óbitos associados à infecção hospitalar, ocorridos em um hospital geral de Sumaré-SP, Brasil [Mortality associated with nosocomial infection, occurring in a general hospital of Sumaré-SP, Brazil]. Revista brasileira de enfermagem, 64(5), 864–869. https://doi.org/10.1590/s0034-71672011000500010

Hrabák, J., Chudáčková, E., & Papagiannitsis, C. C. (2014). Detection of carbapenemases in Enterobacteriaceae: a challenge for diagnostic microbiological laboratories. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 20(9), 839–853. https://doi.org/10.1111/1469-0691.12678

Kalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., Napolitano, L. M., O'Grady, N. P., Bartlett, J. G., Carratalà, J., El Solh, A. A., Ewig, S., Fey, P. D., File, T. M., Jr, Restrepo, M. I., Roberts, J. A., Waterer, G. W., Cruse, P., Knight, S. L., & Brozek, J. L. (2016). Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 63(5), e61–e111. https://doi.org/10.1093/cid/ciw353

Leiser, J. J., Tognim, M. C. B., Bedendo, (2007) J. Infecções hospitalares em um centro de terapia intensiva de um hospital de ensino no norte do Paraná. Ciência, Cuidado e Saúde, 6(2):181–186.

Livermore, D. M., Warner, M., Mushtaq, S., Doumith, M., Zhang, J., & Woodford, N. (2011). What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. International journal of antimicrobial agents, 37(5), 415–419. https://doi.org/10.1016/j.ijantimicag.2011.01.012

Loureiro, R.J., Roque, F., Teixeira Rodrigues, A., Herdeiro, M. T., Ramalheira, E. (2016) O uso de antibióticos e as resistências bacterianas: breves notas sobre a sua evolução. Revista Portuguesa de Saúde Pública, 34(1):77-84. https://doi.org/10.1016/j.rpsp.2015.11.003

Luyt, C. E., Bréchot, N., Trouillet, J. L., & Chastre, J. (2014). Antibiotic stewardship in the intensive care unit. Critical care (London, England), 18(5), 480. https://doi.org/10.1186/s13054-014-0480-6

Mirón-Rubio M. (2021). Treatment of infections caused by multi-resistant microorganisms in hospital at home units. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 34 Suppl 1(Suppl1), 18–21. https://doi.org/10.37201/req/s01.05.2021

Muzlovič, I., & Štubljar, D. (2019). Stress ulcer prophylaxis as a risk factor for tracheal colonization and hospital-acquired pneumonia in intensive care patients: impact on latency time for pneumonia. Acta clinica Croatica, 58(1), 72–86. https://doi.org/10.20471/acc.2019.58.01.10

de Oliveira, A. C., Silva, R. S., Díaz, M. E., & Iquiapaza, R. A. (2010). Bacterial resistance and mortality in an intensive care unit. Revista latino-americana de enfermagem, 18(6), 1152–1160. https://doi.org/10.1590/s0104-11692010000600016

de Oliveira, A. C., & Damasceno, Q. S. (2010). Superfícies do ambiente hospitalar como possíveis reservatórios de bactérias resistentes: uma revisão [Surfaces of the hospital environment as possible deposits of resistant bacteria: a review]. Revista da Escola de Enfermagem da U S P, 44(4), 1118–1123. https://doi.org/10.1590/s0080-62342010000400038

OPAS. Organización Panamericana de la Salud. (2010). Informe Anual de la Red de Monitoreo/ Vigilancia de la Resistencia a los Antibióticos. Disponível em: http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=24101&Itemid=270&lang=en

Pinto, F.D.M., Simas, D.M., Baldin, C.P., Limberger, I.I., Cassol, R., Antochevis, L.C, Vieira, F.J., Ribeiro, V.B., Magagnin, C.M., Rozales, F.P., Falci, D.R. (2014) Prevalência de carbapenemases em enterobatérias resistentes a carbapenemicos em quatro hospitais terciários de Porto Alegre. Clinical Biomedical Research,34(1):47–52.

Sousa, M.A., Medeiros, N.M., Carneiro, J.R., Cardoso, A.M. Hemoculturas positivas de pacientes da unidade de terapia intensiva de um hospital escola de goiânia-go, entre 2010 e 2013. (2014) Revista Estudos Vida e Saúde,41(3):627–35.

Souza, E.S., Belei, R.A., Carrilho, C.M.D.M., Matsuo, T., Yamada-Ogatta, S.F., Andrade, G., Perugini, M.R.E., Pieri, F.M., Dessunti, E.M., Kerbauy, G. Mortality and risks related to healthcare-associated infection. (2015) Texto & Contexto Enfermagem,24(1):220–228. DOI: 10.1590/0104-07072015002940013

Surveillance C. (2020). Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2014-2018. Canada communicable disease report = Releve des maladies transmissibles au Canada, 46(5), 99–112. https://doi.org/10.14745/ccdr.v46i05a01

Tuon, F. F., Graf, M. E., Merlini, A., Rocha, J. L., Stallbaum, S., Arend, L. N., & Pecoit-Filho, R. (2017). Risk factors for mortality in patients with ventilator-associated pneumonia caused by carbapenem-resistant Enterobacteriaceae. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 21(1), 1–6. https://doi.org/10.1016/j.bjid.2016.09.008

Vincent, J. L., Rello, J., Marshall, J., Silva, E., Anzueto, A., Martin, C. D., Moreno, R., Lipman, J., Gomersall, C., Sakr, Y., Reinhart, K., & EPIC II Group of Investigators (2009). International study of the prevalence and outcomes of infection in intensive care units. JAMA, 302(21), 2323–2329. https://doi.org/10.1001/jama.2009.1754

Zaha, D. C., Kiss, R., Hegedűs, C., Gesztelyi, R., Bombicz, M., Muresan, M., Pallag, A., Zrinyi, M., Pall, D., Vesa, C. M., & Micle, O. (2019). Recent Advances in Investigation, Prevention, and Management of Healthcare-Associated Infections (HAIs): Resistant Multidrug Strain Colonization and Its Risk Factors in an Intensive Care Unit of a University Hospital. BioMed research international, 2019, 2510875. https://doi.org/10.1155/2019/2510875

Downloads

Published

26/07/2022

How to Cite

MENEZES, J. M. de A. de .; NASCIMENTO, D. Z. do .; MARQUES, G. M. .; FORTUNA, C. T. .; SOARES, A. de S. .; SCHUELTER-TREVISOL, F. Carbapenem-resistant bacteria in an intensive care unit: prevalence and associated factors. Research, Society and Development, [S. l.], v. 11, n. 10, p. e157111032629, 2022. DOI: 10.33448/rsd-v11i10.32629. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/32629. Acesso em: 4 oct. 2022.

Issue

Section

Health Sciences